ID: ALA5268063

Max Phase: Preclinical

Molecular Formula: C44H41ClN8O7S

Molecular Weight: 861.38

Associated Items:

Representations

Canonical SMILES:  Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCCCNC(=O)c1ccc(COc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)cc1)c1nnc(C)n1-2

Standard InChI:  InChI=1S/C44H41ClN8O7S/c1-23-24(2)61-44-36(23)38(27-13-15-29(45)16-14-27)48-31(39-51-50-25(3)52(39)44)21-35(55)46-19-4-5-20-47-40(56)28-11-9-26(10-12-28)22-60-33-8-6-7-30-37(33)43(59)53(42(30)58)32-17-18-34(54)49-41(32)57/h6-16,31-32H,4-5,17-22H2,1-3H3,(H,46,55)(H,47,56)(H,49,54,57)/t31-,32?/m0/s1

Standard InChI Key:  GSUSWGRLBKUPJT-CYZZXXEPSA-N

Associated Targets(Human)

MM1.S 1111 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MV4-11 7307 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cereblon/Bromodomain-containing protein 4 275 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 861.38Molecular Weight (Monoisotopic): 860.2507AlogP: 5.50#Rotatable Bonds: 13
Polar Surface Area: 194.05Molecular Species: NEUTRALHBA: 12HBD: 3
#RO5 Violations: 3HBA (Lipinski): 15HBD (Lipinski): 3#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.59CX Basic pKa: 4.44CX LogP: 4.54CX LogD: 4.53
Aromatic Rings: 5Heavy Atoms: 61QED Weighted: 0.10Np Likeness Score: -0.87

References

1. Ding M, Shao Y, Sun D, Meng S, Zang Y, Zhou Y, Li J, Lu W, Zhu S..  (2023)  Design, synthesis, and biological evaluation of BRD4 degraders.,  78  [PMID:36563515] [10.1016/j.bmc.2022.117134]

Source